Jim Cramer Highlights Opportunities Beyond AI in Monthly Portfolio Update UK Supermarkets Push Back Against Proposed Price Caps on Essential Food Items Gold and Bitcoin ETF Outflows Signal Shift Away from Debasement Trade CapitaLand Unveils S14 Billion Life Sciences Hub Geneo to Drive Innovation Reddit Shares Slide Nearly 6 After Meta Launches Standalone Forum App Chinas Humanoid Robot Ambitions Elon Musk Highlights Competitive Threat GTN Q1 2026 Earnings EPS Misses Estimates as Media Headwinds Persist CFBK Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher WW International Q1 2026 Earnings EPS Misses Estimates Amid Strategic Challenges Stock Surges Bicycle Therapeutics BCYC Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues ONCY Q3 2025 Earnings WiderthanExpected Loss Amid Clinical Progress INFU Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Strength IREN Limited IREN Dips 212 as Shares Test Key Support Levels Harvard Ave Acquisition Corporation Rights HAVAR Edges Higher on Modest Uptick STRD Preferred Stock Holds Steady Near Support as Trading Remains Muted Nuveen Mortgage and Income Fund JLS Edges Higher Amid Cautious FixedIncome Sentiment Empery Digital Inc EMPD Retreats After Failed Upside Test Support at 472 in Focus Charter Communications Agrees to Acquire Liberty Broadband at Enhanced Terms Scholastic Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Charter Communications CHTR Holds Near Support as Modest Decline Continues Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher VEON Q1 2026 Earnings EPS Beat Underpins Operational Resilience Nomad Foods Q1 2026 Earnings EPS Surprises 214 Above Estimates Amid Weaker Stock Reaction Alpine Income Property Trust Inc PINE Q1 2026 Earnings EPS Misses Analyst Expectations as Stock Advances Symbotic SYM Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Optimism ClearSign Technologies CLIR Q1 2026 Earnings WiderThanExpected Loss Stalls Recovery Hopes MLYS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Ahead of Key Trial Data